Hjem › Meningiom › Ohio › Columbus
Meningiom kliniske forsøg i Columbus, OH
6 studier for Meningiom søger deltagere på steder i og omkring Columbus (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
RekruttererFase 2
- Mount Carmel East Hospital, Columbus
- The Mark H Zangmeister Center, Columbus
- Mount Carmel Health Center West, Columbus
- og 6 flere
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
RekruttererFase 2
- The Ohio State University College of Medicine (OSUCOM), Columbus
RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma
RekruttererFase 1/2
- Ohio State University Comprehensive Cancer Center, Columbus
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
RekruttererFase 1/2
- Nationwide Children's Hospital, Columbus
Cognitive Status After Removal of Skull Base Meningioma
RekruttererObservationsstudie
- Ohio State University Wexner Medical Center, Columbus
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
RekruttererFase 1/2
- Ohio State University, Columbus
Meningiom forsøg i andre byer
- New York City, NY8 studier
- Miami, FL7 studier
- Boston, MA6 studier
- San Francisco, CA5 studier
- San Diego, CA5 studier
- Atlanta, GA5 studier
- Jacksonville, FL5 studier
- Phoenix, AZ4 studier
- Arlington, VA4 studier
- Houston, TX4 studier
- Detroit, MI4 studier
- Durham, NC3 studier
Andre studier i Columbus
- Ikke-småcellet lungecancer56 studier
- Brystkræft39 studier
- Ægstockræft39 studier
- Kræft (alle typer)38 studier
- Lungecancer37 studier
- Akut myeloid leukæmi35 studier
- Kronisk lymfatisk leukæmi28 studier
- Metastatisk cancer27 studier
- Livmoderslimhindekræft25 studier
- Colorektal kræft24 studier
- Prostatakræft24 studier
- Multipelt myelom24 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.